Anzeige
Meldung des Tages: Wenn Lieferketten brechen: Dieses Metall könnte zum nächsten Engpass werden

Talphera News

Aktie
WKN:  A3DWPN ISIN:  US00444T2096 US-Symbol:  TLPH Branche:  Pharmazeutika Land:  USA
0,7726 $
+0,0084 $
+1,10%
0,6711 € 26.03.26
Depot/Watchlist
Marktkapitalisierung *
15,86 Mio. €
Streubesitz
33,43%
KGV
-3,06
Index-Zuordnung
-

Talphera News

25.03.26 - PR Newswire
Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026
Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026 PR Newswire
23.03.26 - PR Newswire
Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update PR Newswire
18.03.26 - PR Newswire
Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026
Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026 PR Newswire
02.03.26 - PR Newswire
Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial
Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-​CRRT Registrational Trial PR Newswire
12.11.25 - PR Newswire
Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update PR Newswire
05.11.25 - PR Newswire
Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025
Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025 PR Newswire
21.10.25 - PR Newswire
Talphera Announces the Appointment of Joe Todisco to Board of Directors
Talphera Announces the Appointment of Joe Todisco to Board of Directors PR Newswire
08.09.25 - PR Newswire
Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market
Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market PR Newswire
25.08.25 - PR Newswire
Talphera Announces Achievement of 17 Patient Enrollment Milestone in NEPHRO CRRT Pivotal Trial
Talphera Announces Achievement of 17 Patient Enrollment Milestone in NEPHRO CRRT Pivotal Trial PR Newswire
14.08.25 - PR Newswire
Talphera Announces Second Quarter 2025 Financial Results and Provides Corporate Update
Talphera Announces Second Quarter 2025 Financial Results and Provides Corporate Update PR Newswire
07.08.25 - PR Newswire
Talphera to Host Second Quarter Financial Results and Corporate Update Call and Webcast on Thursday, August 14, 2025
Talphera to Host Second Quarter Financial Results and Corporate Update Call and Webcast on Thursday, August 14, 2025 PR Newswire
14.05.25 - PR Newswire
Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update
Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update PR Newswire
07.05.25 - PR Newswire
Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 14, 2025
Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 14, 2025 PR Newswire
31.03.25 - PR Newswire
Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update PR Newswire
31.03.25 - PR Newswire
Talphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to $14.8 Million
Talphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to ...

Newssuche

Videos

newspaper
23.03.26 +6,96%
Technical Trading: Gold Long nach Absturz
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »